21 April 2025 : Clinical Research
[In Press] Self-Management-Centric Cardiac Rehabilitation for Acute Coronary Syndrome Patients During the COVID-19 Pandemic
Yiwen Wang1ABCE, Haowen Shi1BCEF, Min Zhang1BDF, Yang Duan1D, Zhi Li1BDF, Lei Chen1BCD, Yixuan Wu1BCF, Yanfei Ren1BF, Yuan Lu1ADEGDOI: 10.12659/MSM.947235
Med Sci Monit In Press; DOI: 10.12659/MSM.947235
Available online: 2025-04-21, In Press, Corrected Proof
Publication in the "In-Press" formula aims at speeding up the public availability of the pending manuscript while waiting for the final publication. The assigned DOI number is active and citable. The availability of the article in the Medline, PubMed and PMC databases as well as Web of Science will be obtained after the final publication according to the journal schedule
Abstract
BACKGROUND
The COVID-19 pandemic accelerated the adoption of home-based cardiac telerehabilitation (HBCTR), yet evidence on the role of intensified self-management in outcomes for acute coronary syndrome (ACS) patients remains limited.
MATERIAL AND METHODS
In this single-center retrospective cohort study (2019-2021), 1627 ACS patients were stratified into 2 groups: those who finished a self-management-centric HBCTR (SMCCRF) plan, and the SMCCR-unfinished (SMCCRNF) group (≥1 missed tele-coaching sessions). The primary outcome was major adverse cardiac events (MACEs); secondary outcomes included self-perceived disease awareness assessed by the Coronary Artery Disease Education Questionnaire-Short Version (CADEQ-SV), behavioral metrics (medication adherence, physical exercise), and risk factor control. Propensity score matching (1: 1, calliper=0.1 standard deviation) generated 619 matched pairs.
RESULTS
Over a median follow-up of 23.39 months, the SMCCRF group had lower MACEs rates compared to the SMCCRNF group (7.43% vs 18.74%; HR 0.43, 95% CI 0.30-0.60; P<0.001), with consistent benefits across subgroups. Secondary outcomes favored the SMCCRF group, including higher CADEQ-SV scores at 12 and 36 months (P=0.02), better medication and exercise adherence (both P<0.001), and improved control of blood pressure, low-density lipoprotein cholesterol, and smoking cessation (all P<0.01). However, changes in cardiac function were similar between the 2 groups, and fluctuations of the aforementioned secondary outcomes were observed during long-term follow-up.
CONCLUSIONS
SMCCR was associated with reduced cardiovascular risk and enhanced behavioral outcomes in ACS patients during the pandemic, suggesting a dose-dependent relationship between missed sessions and adverse outcomes. The findings support integrating self-management strategies into post-ACS care, pending validation in prospective trials.
Keywords: COVID-19; Cardiac Rehabilitation; Acute Coronary Syndrome; Self-Management
Editorial
01 May 2025 : Editorial
Editorial: Surveillance of Seasonal Respiratory Syncytial Virus (RSV) Infection in Children and Vulnerable Adults Drives Vaccine Development and New Immunization ProgramsDOI: 10.12659/MSM.949558
Med Sci Monit 2025; 31:e949558
In Press
Clinical Research
Impact of Periacetabular Osteotomy on Cartilage Enhancement in Crowe Group I Hip Dysplasia: A Short-Term An...Med Sci Monit In Press; DOI: 10.12659/MSM.946764
Database Analysis
Role of Body Fat and Metabolic Rate in Site-Specific Fracture Risk: A 20-Year Taiwanese Cohort StudyMed Sci Monit In Press; DOI: 10.12659/MSM.947660
Review article
Advancements in Non-Invasive Intracranial Pressure Monitoring via Optic Nerve Sheath Diameter MeasurementMed Sci Monit In Press; DOI: 10.12659/MSM.947237
Clinical Research
Use of the Zebris Ultrasonic Three-Dimensional Motion Analysis System to Evaluate Range of Motion of the Ce...Med Sci Monit In Press; DOI: 10.12659/MSM.948203
Most Viewed Current Articles
17 Jan 2024 : Review article 9,026,500
Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron VariantDOI :10.12659/MSM.942799
Med Sci Monit 2024; 30:e942799
16 May 2023 : Clinical Research 703,391
Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...DOI :10.12659/MSM.940387
Med Sci Monit 2023; 29:e940387
01 Mar 2024 : Editorial 31,291
Editorial: First Regulatory Approvals for CRISPR-Cas9 Therapeutic Gene Editing for Sickle Cell Disease and ...DOI :10.12659/MSM.944204
Med Sci Monit 2024; 30:e944204
28 Jan 2024 : Review article 25,195
A Review of IgA Vasculitis (Henoch-Schönlein Purpura) Past, Present, and FutureDOI :10.12659/MSM.943912
Med Sci Monit 2024; 30:e943912